Clinical trials
Recruiting Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
182 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 16 |
| 2023 | 21 |
| 2024 | 31 |
| 2025 | 47 |
| 2026 | 30 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 182 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 8 |
| Northern Jiangsu People's Hospital | 8 |
| Hospices Civils de Lyon | 6 |
| Massachusetts General Hospital | 5 |
| Chinese University of Hong Kong | 4 |
| Institute of Liver and Biliary Sciences, India | 4 |
| Mayo Clinic | 4 |
| GlaxoSmithKline | 3 |
| M.D. Anderson Cancer Center | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 182 |
| Liver Cirrhosis | 29 |
| Hypertension, Portal | 24 |
| Non-alcoholic Fatty Liver Disease | 24 |
| Carcinoma, Hepatocellular | 19 |
| Fatty Liver | 13 |
| Liver Diseases | 12 |
| Ascites | 10 |
| Hepatic Encephalopathy | 8 |
| Liver Neoplasms | 7 |
Trials
Showing 26 to 50 of 182. Each trial links to its page on Pharma Observatory.
82 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.